ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Shree Ganesh Biotech (India)'s annualizedNet Income for the quarter that ended in Mar. 2026 was ₹-5.97 Mil.
Shree Ganesh Biotech (India)'s average Total Assets over the quarter that ended in Mar. 2026 was ₹638.03 Mil. Therefore, Shree Ganesh Biotech (India)'s annualized ROA % for the quarter that ended in Mar. 2026 was -0.94%.
The historical rank and industry rank for Shree Ganesh Biotech (India)'s ROA % or its related term are showing as below:
BOM:539470'
s ROA % Range Over the Past 10 Years
Min: 0.37 Med: 1.59 Max: 30.17
Current: 0.8
During the past 12 years, Shree Ganesh Biotech (India)'s highest ROA % was 30.17%. The lowest was 0.37%. And the median was 1.59%.
BOM:539470's ROA % is ranked worse than 68.34% of 259
companies
in the Agriculture industry
Industry Median: 3.27
vs BOM:539470: 0.80
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Shree Ganesh Biotech (India) ROA % Related Terms
Shree Ganesh Biotech (India) ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Ganesh Biotech (India) ROA % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s ROA % distribution charts can be found below:
* The bar in red indicates where Shree Ganesh Biotech (India)'s ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Shree Ganesh Biotech (India) (BOM:539470) has a ROA % of -0.94% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shree Ganesh Biotech (India) and its competitors. Over the past decade, Shree Ganesh Biotech (India)'s ROA % has ranged from 0.37 to 30.17. According to the industry distribution chart, Shree Ganesh Biotech (India) ranks #177 out of 259 companies in the Agriculture industry, placing it in the top 68.3%.
Is Shree Ganesh Biotech (India)'s ROA % too high?
Shree Ganesh Biotech (India)'s current ROA % is -0.94%. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 30.17. Based on the distribution chart, Shree Ganesh Biotech (India) ranks #177 out of 259 companies in the Agriculture industry, which is below the industry midpoint. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s ROA % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shree Ganesh Biotech (India) ranks #177 out of 259 companies for ROA %. This places Shree Ganesh Biotech (India) in the lower half of its industry. The industry median ROA % is 3.27. Historically, Shree Ganesh Biotech (India)'s own ROA % has ranged from 0.37 to 30.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for an Agriculture company?
The median ROA % among Agriculture companies is 3.27, based on 259 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shree Ganesh Biotech (India) and its competitors. For the Agriculture industry, the median ROA % is 3.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Ganesh Biotech (India)'s current ROA % is -0.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.20, compared to a current price of ₹0.54 — trading 170% above its estimated fair value. The current ROA % is -0.94%. Shree Ganesh Biotech (India)'s overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current ROA % is -0.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued.
The current stock price of ₹0.54 is trading 170% above its estimated GF Value™ of ₹0.20.
GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.
Key valuation signals for BOM:539470:
ROA %: -0.94%
GF Value™: ₹0.20 vs. price of ₹0.54 (170% above fair value)
No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
45GF Score
Get the complete analysis for BOM:539470
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539470 has been successfully added to your 
